Who Should Not Take GLP-1 Weight Loss Medication?

Last updated: 8 August 2026

TL;DR: GLP-1 weight loss medication is not suitable for everyone. It should not be used by people with certain thyroid cancers or the MEN2 syndrome, a known allergy to the medicine, or in pregnancy. Others, including those with a history of pancreatitis or some digestive conditions, need caution and clinical judgement. A proper assessment screens for all of these.

Knowing who should not take a medicine is as important as knowing who benefits. This guide sets out the main contraindications and cautions for GLP-1 weight loss treatment and explains why a clinical assessment exists to catch them. It is educational, is not a self-diagnosis tool, and does not replace a consultation with a prescriber; always follow the patient information leaflet for your specific product.

Who Is Not Eligible for GLP-1 Weight Loss Medication?

Some groups should not take these medicines at all. Contraindications are absolute reasons not to use a medicine, and they are screened for before any prescription.

• A known hypersensitivity (allergy) to the medicine or its ingredients.
• A personal or family history of medullary thyroid carcinoma, or the endocrine syndrome MEN2, for which these medicines carry a specific warning.
• Pregnancy, and generally while breastfeeding.

Eligibility also depends on meeting the criteria the medicine is licensed for, such as a qualifying BMI. Being outside a contraindication is necessary but not sufficient; a prescriber assesses the whole picture.

What Medical Conditions Are Contraindications or Cautions?

Beyond absolute contraindications, several conditions call for caution and careful clinical judgement rather than an automatic no. According to product information and safety reviews (including Drug Design, Development and Therapy, 2026), history of pancreatitis and significant digestive conditions are important to disclose.

• History of pancreatitis: requires caution; the MHRA updated GLP-1 product information in January 2026 to reflect a small risk of severe acute pancreatitis.
• Severe gastrointestinal disease or gastroparesis: may make GLP-1 treatment unsuitable or need extra care.
• Type 1 diabetes and diabetic ketoacidosis: these medicines are not a treatment for them.
• Gallbladder disease: relevant given the association with biliary problems.

These are reasons to assess carefully, not always to refuse, which is exactly what a clinical consultation is for.

Can You Take GLP-1 Medication While Pregnant or Breastfeeding?

GLP-1 weight loss medication is not recommended in pregnancy and should be stopped if you are planning to conceive. Weight loss is not advised during pregnancy, and there is insufficient safety data to support use.

Manufacturer guidance typically advises stopping these medicines a set period before a planned pregnancy, so anyone trying to conceive should raise this with their prescriber in advance. Breastfeeding is generally a reason not to use them as well. If pregnancy is possible, reliable contraception and an open conversation with your prescriber are important.

What Medications and Conditions Need Extra Caution?

Some medicines and situations interact with GLP-1 treatment and need review, even when they are not outright contraindications. Because GLP-1 medicines slow stomach emptying, they can affect how other medicines are absorbed.

• Insulin or sulfonylureas: risk of low blood sugar may mean dose adjustments.
• Oral medicines with narrow timing or absorption needs: may be affected by slower digestion.
• A history of eating disorders: needs sensitive clinical consideration.
• Being under 18, or frailty in older adults: requires specific judgement.

This is why a full medication and medical history is part of any responsible assessment, rather than a quick checkbox.

How Does a Clinical Assessment Screen for These Risks?

A proper assessment exists precisely to identify contraindications and cautions before a medicine is supplied. It gathers your medical and family history, current medicines, and relevant conditions, and a prescriber weighs them against the licence and the evidence.

Bolt Pharmacy uses a structured clinical assessment with named prescribers, so that eligibility and safety are checked by an accountable clinician rather than assumed. If any of the contraindications or cautions above apply to you, that is a conversation to have openly at assessment; disclosing your full history is what allows a safe decision. For the eligibility criteria themselves, see the related guide.

Related Guides

• Am I Eligible for Weight Loss Medication?
• GLP-1 Warning Signs: When Weight Loss Medication Side Effects Need Medical Attention
• Are Weight Loss Injections Safe? What the UK Data Actually Shows
• How Bolt Prescribes: Our Clinical Process
• Do GLP-1 Medications Have Benefits Beyond Weight Loss?

Key Takeaways

• GLP-1 weight loss medication is not suitable for everyone and is screened before prescribing.
• It should not be used with certain thyroid cancers or MEN2, a known allergy, or in pregnancy.
• A history of pancreatitis or significant digestive conditions calls for caution.
• It is not a treatment for type 1 diabetes or diabetic ketoacidosis.
• Slowed digestion can affect other medicines, so a full medication history matters.
• A structured clinical assessment exists to catch all of these before treatment.

Frequently Asked Questions

Who cannot take Mounjaro or Wegovy?
People with a known allergy to the medicine, a personal or family history of medullary thyroid carcinoma or MEN2, and those who are pregnant should not take it. Others, such as people with a history of pancreatitis or significant digestive disease, need caution and clinical judgement.

Can I take a weight loss injection if I've had pancreatitis?
A history of pancreatitis calls for caution rather than an automatic no, and must be disclosed at assessment. The MHRA updated GLP-1 product information in January 2026 to reflect a small risk of severe acute pancreatitis. A prescriber will weigh your history carefully.

Can I take GLP-1 medication while pregnant or trying to conceive?
No. It is not recommended in pregnancy and should be stopped if you are planning to conceive, as weight loss is not advised during pregnancy and safety data are insufficient. Manufacturer guidance advises stopping a set period before a planned pregnancy; discuss timing with your prescriber.

Does GLP-1 medication interact with other medicines?
It can. Because these medicines slow stomach emptying, they may affect how other medicines are absorbed, and they can require dose adjustments with insulin or sulfonylureas due to low blood sugar risk. Share your full medication list at assessment so a prescriber can review it.

Published by Bolt Pharmacy, a GPhC-registered UK pharmacy. Sources: manufacturer Summaries of Product Characteristics for Mounjaro and Wegovy (electronic medicines compendium) and MHRA prescribing information; safety and risk-mitigation review, Drug Design, Development and Therapy (2026); acute pancreatitis evidence, BMJ (2026) and MHRA guidance update (January 2026). This guide is educational, not a self-assessment tool, and does not replace clinical screening. Always follow the leaflet for your product. Reflects published information as of August 2026.